Speechlessness in Gilles de la Tourette Syndrome Cannabis-Based Medicines Improve Severe Vocal Blocking Tics in Two Patients.
We report the cases of two young German male patients with treatment-resistant Tourette syndrome (TS), who suffer from incapacitating stuttering-like speech disfluencies caused by vocal blocking tics and palilalia. Case 1 a 19-year old patient received medical cannabis at a dose of 1 × 0.1 g cannabis daily. Case 2 a 16-year old patient initially received dronabinol at a maximum dose of 22.4-33.6 mg daily. Both treatments provided significant symptom improvement of vocal blocking tics as well as of comorbid conditions and were well tolerated. Thus, cannabis-based medicine appears to be effective in treatment-resistant TS patients with vocal blocking tics.